Adults aged 18 years and older with a diagnosis of Prurigo Nodularis, defined by the presence of at least ten itchy nodules secondary to chronic pruritus present on at least two different body surface areas (e.g. both arms, one arm and one leg, one arm and the anterior trunk, or anterior and posterior trunk) may qualify to participate.
Participants will receive investigational oral medication (active study drug or placebo that has no active ingredient). This drug is not approved yet for any use in any country. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.
Study participation will last up to 14 weeks and involve 7 visits to the study centre. In addition, up to 2 visits will occur by telephone.
Email Tina Craig, Clinical Research Coordinator at DermEffects to register